Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
New Biotechnology is Scopus-indexed (Q1, CiteScore 9.2), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 1871-6784Verify ISSN ↗1876-4347Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 62 / 325 | 81st | Q1 |
| Molecular Biology | 81 / 414 | 80th | Q1 |
| Bioengineering | 40 / 168 | 76th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q1, CiteScore 9.2.
New Biotechnology is Q1 in Biotechnology (rank 62 of 325), Q1 in Molecular Biology (rank 81 of 414) and Q1 in Bioengineering (rank 40 of 168), by CiteScore 2025.
New Biotechnology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.2, which places it in quartile Q1 at the 81st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.062, quartile Q1, with an H-index of 117.
The publisher lists an article processing charge of about US$3,670 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
New Biotechnology is published by Elsevier B.V. Its print ISSN is 1871-6784 and its online ISSN is 1876-4347.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
New Biotechnology has an h-index of 112 and a 2-year mean of 1.72 citations per paper (OpenAlex). Its Scopus CiteScore is 9.2, quartile Q1. On 2-year citations it ranks #192 of 309 Scopus journals in Biotechnology.
New Biotechnology published 561 papers in 2025; its busiest recent year was 2018 with 563. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from South Korea (14.8%), United States (9.9%) and Netherlands (8.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.